173 related articles for article (PubMed ID: 12933658)
21. Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels.
van de Donk NW; Kamphuis MM; van Kessel B; Lokhorst HM; Bloem AC
Blood; 2003 Nov; 102(9):3354-62. PubMed ID: 12855556
[TBL] [Abstract][Full Text] [Related]
22. Rho/ROCK pathway as a target of tumor therapy.
Rattan R; Giri S; Singh AK; Singh I
J Neurosci Res; 2006 Feb; 83(2):243-55. PubMed ID: 16385577
[TBL] [Abstract][Full Text] [Related]
23. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
24. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
[TBL] [Abstract][Full Text] [Related]
25. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts.
Vogt A; Qian Y; McGuire TF; Hamilton AD; Sebti SM
Oncogene; 1996 Nov; 13(9):1991-9. PubMed ID: 8934546
[TBL] [Abstract][Full Text] [Related]
26. Prenylation of Rho G-proteins: a novel mechanism regulating gene expression and protein stability in human trabecular meshwork cells.
Stubbs EB; Von Zee CL
Mol Neurobiol; 2012 Aug; 46(1):28-40. PubMed ID: 22396212
[TBL] [Abstract][Full Text] [Related]
27. The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells.
van de Donk NW; Kamphuis MM; Lokhorst HM; Bloem AC
Leukemia; 2002 Jul; 16(7):1362-71. PubMed ID: 12094262
[TBL] [Abstract][Full Text] [Related]
28. Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells.
Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
J Clin Endocrinol Metab; 2003 Jul; 88(7):3021-6. PubMed ID: 12843138
[TBL] [Abstract][Full Text] [Related]
29. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
Fromigué O; Haÿ E; Modrowski D; Bouvet S; Jacquel A; Auberger P; Marie PJ
Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222
[TBL] [Abstract][Full Text] [Related]
30. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
31. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
Crick DC; Andres DA; Danesi R; Macchia M; Waechter CJ
J Neurochem; 1998 Jun; 70(6):2397-405. PubMed ID: 9603204
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
33. Increased RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells by lovastatin.
Von Zee CL; Richards MP; Bu P; Perlman JI; Stubbs EB
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2816-23. PubMed ID: 19151402
[TBL] [Abstract][Full Text] [Related]
34. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ
Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051
[TBL] [Abstract][Full Text] [Related]
35. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
36. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone.
Johnson TE; Zhang X; Bleicher KB; Dysart G; Loughlin AF; Schaefer WH; Umbenhauer DR
Toxicol Appl Pharmacol; 2004 Nov; 200(3):237-50. PubMed ID: 15504460
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.
Stark WW; Blaskovich MA; Johnson BA; Qian Y; Vasudevan A; Pitt B; Hamilton AD; Sebti SM; Davies P
Am J Physiol; 1998 Jul; 275(1):L55-63. PubMed ID: 9688935
[TBL] [Abstract][Full Text] [Related]
38. Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells.
Wang IK; Lin-Shiau SY; Lin JK
Pharmacol Toxicol; 2000 Feb; 86(2):83-91. PubMed ID: 10728920
[TBL] [Abstract][Full Text] [Related]
39. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
[TBL] [Abstract][Full Text] [Related]
40. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
